Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Personalized Medicine In 2010: Welcome To The Establishment

Executive Summary

Evidence of progress for molecular diagnostics and instrumentation, the mainstays of the personalized medicine toolkit, was considerable in 2010. Much of the activity centered on sequencing, although its general utility in clinical diagnostics has not yet been demonstrated and whether measurements of gene expression can form the basis for a plethora of molecular tests also remains an open question. In abbreviated form, we list some of the important dealmaking activities and trends of the year.

Related Content

Provider Trends: ACOs Begin to Take Shape
GE Acquires Clarient To Anchor Its Molecular IVD Business
BGI Touts Eventual Merck Deal
Good Start Genetics Raises $18 Million For Sequencing-Based Testing
In Vitro Diagnostics: The Quest for Growth
The How And When Of Applying Sequencing To Clinical Diagnostics
The How And When Of Applying Sequencing To Clinical Diagnostics
Companion Diagnostics Move Toward Mainstream Drug Development
CardioDx: Bringing Molecular Diagnostics Into the Cardiovascular Arena
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts